NCT07420907 Study of the Progression of Chronic Cardiovascular Conditions
| NCT ID | NCT07420907 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Prolaio |
| Condition | Cardiovascular Disease (CVD) |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2025-10-30 |
| Primary Completion | 2030-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2025-10-30 with a primary completion date of 2030-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will collect physiologic data in patients with cardiovascular conditions and observe the natural history of those conditions for research purposes.
Eligibility Criteria
Inclusion Criteria: * 18 years of age and older * Ability to understand study assessments and give informed consent to data collection * Ability to comply with the study protocol * Ability to understand and respond to instructions in English * Has diagnosis of qualifying Cardiovascular Disease(s) (CVD) including but not limited to: HF, AS, HCM, HTN, DCM, etc. * Resides in the United States Exclusion Criteria: * Allergy to adhesive used in biosensor patch * Life threatening disease process outside of area under study, such as actively treated cancer or pre/post-transplant such as hepatic failure; end-stage renal disease. * Severe CVD defined by hospital admission for cardiac diagnosis within 30 days of enrollment or documentation of NYHA functional class IV * Self-reported weight of 400 pounds or greater
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07420907 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cardiovascular Disease (CVD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07420907 currently recruiting?
Yes, NCT07420907 is actively recruiting participants. Contact the research team at OCOROstudy@prolaio.com for enrollment information.
Where is the NCT07420907 trial being conducted?
This trial is being conducted at Chicago, United States.
Who is sponsoring the NCT07420907 clinical trial?
NCT07420907 is sponsored by Prolaio. The trial plans to enroll 5,000 participants.